About Kirk Malloy
Kirk Malloy is the founder and principal of BioAdvisors, LLC, a consulting firm serving life science, molecular diagnostics and genomics companies. He is also an independent board member of Araceli Biosciences, which builds imaging hardware and AI analysis software for drug discovery labs.
Earlier in his career he held senior roles at Illumina, Biosite and QIAGEN, and was founder and chief executive officer of Verogen, Inc., which QIAGEN later acquired. He has also served on several private and public boards, including NanoString Technologies, DermTech and Rapid Micro Biosystems, where he chairs the board.
Experience
This experience comes from official bios and from SEC filings. For roles taken from filings, the years are when the filings name Kirk Malloy in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Kirk Malloy works with at each company, as listed on that company's latest Form D.
